Marie Skłodowska-Curie actions has awarded €2,887,054.24 to an EU consortium, including MRC Technology, to provide training for 11 young researchers in innovative therapeutic strategies. EVOluTION, the European Vascular Interventions and Therapeutic Innovation Network, aims to find novel approaches to manage chronic vascular and metabolic diseases affecting the increasing ageing population, focusing on early detection and prevention.

MRC Technology will receive €273,287.88 and the project starts 1 April 2016.

Further information